Literature DB >> 12426450

Re-introducing honey in the management of wounds and ulcers - theory and practice.

Peter C Molan1.   

Abstract

Dressing wounds with honey, a standard practice in past times, went out of fashion when antibiotics came into use. Because antibiotic-resistant bacteria have become a widespread clinical problem, a renaissance in honey use has occurred. Laboratory studies and clinical trials have shown that honey is an effective broad-spectrum antibacterial agent that has no adverse effects on wound tissues. As well as having an antibacterial action, honey also provides rapid autolytic debridement, deodorizes wounds, and stimulates the growth of wound tissues to hasten healing and start the healing process in dormant wounds. Its anti-inflammatory activity rapidly reduces pain, edema, and exudate and minimizes hypertrophic scarring. It also provides a moist healing environment for wound tissues with no risk of maceration of surrounding skin and completely prevents adherence of dressings to the wound bed so no pain or tissue damage is associated with dressing changes. Using appropriate dressing practice overcomes potential messiness and handling problems.

Entities:  

Mesh:

Year:  2002        PMID: 12426450

Source DB:  PubMed          Journal:  Ostomy Wound Manage        ISSN: 0889-5899            Impact factor:   2.629


  45 in total

Review 1.  A critical review of modern and emerging absorbent dressings used to treat exuding wounds.

Authors:  India R Sweeney; Mohsen Miraftab; Graham Collyer
Journal:  Int Wound J       Date:  2012-01-17       Impact factor: 3.315

2.  Multicentre prospective observational study on professional wound care using honey (Medihoney™).

Authors:  Bahram Biglari; Arash Moghaddam; Kai Santos; Gisela Blaser; Axel Büchler; Gisela Jansen; Alfred Längler; Norbert Graf; Ursula Weiler; Verena Licht; Anke Strölin; Brigitta Keck; Volker Lauf; Udo Bode; Tyler Swing; Ralph Hanano; Nicolas T Schwarz; Arne Simon
Journal:  Int Wound J       Date:  2012-04-11       Impact factor: 3.315

3.  Use of linseed oil in preventing peri-ileostomy skin excoriation.

Authors:  Sunil Saxena; Seema Suryawanshi; Uday Somashekar; Dhananjaya Sharma
Journal:  Indian J Gastroenterol       Date:  2009 Sep-Oct

4.  Application of Hyperosmotic Nanoemulsions in Wound Healing: Partial Thickness Injury Model in Swine.

Authors:  Sean Connell; Jianming Li; Abigail Durkes; Lynetta Freeman
Journal:  Adv Wound Care (New Rochelle)       Date:  2017-05-01       Impact factor: 4.730

5.  Hyperosmotic Agents and Antibiotics Affect Dissolved Oxygen and pH Concentration Gradients in Staphylococcus aureus Biofilms.

Authors:  Mia Mae Kiamco; Erhan Atci; Abdelrhman Mohamed; Douglas R Call; Haluk Beyenal
Journal:  Appl Environ Microbiol       Date:  2017-03-02       Impact factor: 4.792

Review 6.  Wound care with antibacterial honey (Medihoney) in pediatric hematology-oncology.

Authors:  Arne Simon; Kai Sofka; Gertrud Wiszniewsky; Gisela Blaser; Udo Bode; Gudrun Fleischhack
Journal:  Support Care Cancer       Date:  2005-08-02       Impact factor: 3.603

7.  Manuka honey modulates the release profile of a dHL-60 neutrophil model under anti-inflammatory stimulation.

Authors:  Benjamin A Minden-Birkenmaier; Meghan B Meadows; Kasyap Cherukuri; Matthew P Smeltzer; Richard A Smith; Marko Z Radic; Gary L Bowlin
Journal:  J Tissue Viability       Date:  2020-03-26       Impact factor: 2.932

8.  Antibacterial honey (Medihoney) for wound care of immunocompromised pediatric oncology patients.

Authors:  Arne Simon; Kai Sofka; Gertrud Wieszniewsky; Gisela Blaser
Journal:  GMS Krankenhhyg Interdiszip       Date:  2006-08-30

9.  Traditional medicine in oman: its role in ophthalmology.

Authors:  Radha Shenoy; Alexander Bialasiewicz; Rajiv Khandekar; Badar Al Barwani; Habiba Al Belushi
Journal:  Middle East Afr J Ophthalmol       Date:  2009-04

10.  Wound contraction effects and antibacterial properties of Tualang honey on full-thickness burn wounds in rats in comparison to hydrofibre.

Authors:  Yan-Teng Khoo; Ahmad Sukari Halim; Kirnpal-Kaur B Singh; Noor-Ayunie Mohamad
Journal:  BMC Complement Altern Med       Date:  2010-09-03       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.